NCT07141641|Unknown
Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular Disease and Dialysis Access
1 other identifier
CLN-EA-IP-2
Study Type
expanded_access
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredAug 2025
Brief Summary
Individual patient expanded access requests may be considered for patients who have no other treatment options and are not eligible for an ATEV clinical study.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2025
Completed7 days until next milestone
First Posted
Study publicly available on registry
August 26, 2025
CompletedLast Updated
September 15, 2025
Status Verified
August 1, 2025
First QC Date
August 19, 2025
Last Update Submit
September 8, 2025
Conditions
Interventions
Eligibility Criteria
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Humacyte, Inc.lead
MeSH Terms
Conditions
Vascular Diseases
Condition Hierarchy (Ancestors)
Cardiovascular Diseases
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2025
First Posted
August 26, 2025
Last Updated
September 15, 2025
Record last verified: 2025-08